APA (7th ed.) Citation

García-Romero, N., Palacín-Aliana, I., Madurga, R., Carrión-Navarro, J., Esteban-Rubio, S., Jiménez, B., . . . Ayuso-Sacido, A. (2020). Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma. BMC Medicine, 18(1), 1. https://doi.org/10.1186/s12916-020-01610-0

Chicago Style (17th ed.) Citation

García-Romero, N., et al. "Bevacizumab Dose Adjustment to Improve Clinical Outcomes of Glioblastoma." BMC Medicine 18, no. 1 (2020): 1. https://doi.org/10.1186/s12916-020-01610-0.

MLA (9th ed.) Citation

García-Romero, N., et al. "Bevacizumab Dose Adjustment to Improve Clinical Outcomes of Glioblastoma." BMC Medicine, vol. 18, no. 1, 2020, p. 1, https://doi.org/10.1186/s12916-020-01610-0.